Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial

Devauchelle-Pensec, Valérie, Mariette, Xavier, Jousse-Joulin, Sandrine, Berthelot, Jean-Marie, Perdriger, Aleth, Puéchal, Xavier, Le Guern, Véronique, Sibilia, Jean, Gottenberg, Jacques-Eric, Chiche, Laurent, Hachulla, Eric, Hatron, Pierre Yves, Goeb, Vincent, Hayem, Gilles, Morel, Jacques, Zarnitsky, Charles, Dubost, Jean Jacques, Pers, Jacques Olivier, Nowak, Emmanuel, Saraux, Alain·2014·Annals of Internal Medicine
DOI 10.7326/m13-1085

Cited by (433)

Items 101–200 of 433

  1. A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome
    Maria Juárez, Nieves Díaz, Geoffrey I. Johnston, Saba Nayar, Andrew Payne, Eric Helmer, Dionne Cain, Paulette Williams, Valérie Devauchelle‐Pensec, Benjamin A. Fisher et al. · 2020 · Lara D. Veeken
  2. The Spectrum of Extraglandular Manifestations in Primary Sjögren’s Syndrome
    Ancuţa Mihai, Constantin Căruntu, Ciprian Jurcuț, Florin Cristian Blăjuţ, Mihnea Casian, Daniela Opriș-Belinski, Ruxandra Ionescu, Ana Căruntu · 2023 · Journal of Personalized Medicine
  3. Refractory Primary Sjögren Syndrome Successfully Treated With Bortezomib
    Juan Jakez‐Ocampo, Yemil Atisha‐Fregoso, Luis Llorente · 2015 · JCR Journal of Clinical Rheumatology
  4. Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome
    Kendrick Co Shih, Christie Nicole Lun, Vishal Jhanji, Bernard Yu‐Hor Thong, Louis Hak Tien Tong · 2017 · Journal of Inflammation
  5. Salivary gland ultrasonography in primary Sjögren’s syndrome: opportunities and challenges
    Valérie Devauchelle‐Pensec, Alen Zabotti, Guillermo Carvajal Alegria, Nenad Filipović, Sandrine Jousse‐Joulin, Salvatore De Vita · 2019 · Rheumatology
  6. Effectiveness of abatacept for patients with Sjögren’s syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjögren’s syndrome Endocrinopathy) trial
    Hiroto Tsuboi, Isao Matsumoto, Shinya Hagiwara, Tomoya Hirota, Hiroyuki Takahashi, Hiroshi Ebe, Masahiro Yokosawa, Mizuki Yagishita, Hidenori TAKAHASHI, Izumi Kurata et al. · 2016 · Modern Rheumatology
  7. Targeting primary Sjögren’s syndrome
    Toshio Odani, John A. Chiorini · 2018 · Modern Rheumatology
  8. Efficacy and safety of biological DMARDs modulating B cells in primary Sjögren's syndrome: Systematic review and meta-analysis
    Hind Letaief, Cédric Lukas, Thomas Barnetche, Cécile Gaujoux-Viala, Bernard G Combe, Jacques Morel · 2017 · Joint Bone Spine
  9. Diagnostic accuracy of salivary gland ultrasound in Sjögren’s syndrome: A systematic review and meta-analysis
    Karishma Ramsubeik, Shastri Motilal, Luis Sanchez‐Ramos, Laurie Ann Ramrattan, Gurjit Singh Kaeley, Jasvinder A. Singh · 2020 · Therapeutic Advances in Musculoskeletal Disease
  10. Understanding Fatigue in Sjögren’s Syndrome: Outcome Measures, Biomarkers and Possible Interventions
    Elisabeth Mæland, Samira Tatiyama Miyamoto, Daniel Hammenfors, Valéria Valim, Malin Viktoria Jonsson · 2021 · Frontiers in Immunology
  11. Cardiovascular Involvement in Sjögren’s Syndrome
    Fabiola Atzeni, Francesco Gozza, Giacomo Cafaro, Carlo Perricone, Elena Bartoloni · 2022 · Frontiers in Immunology
  12. Sjögren Syndrome and Other Causes of Sicca in Older Adults
    Alan N. Baer, Brian T. Walitt · 2016 · Clinics in Geriatric Medicine
  13. New developments in Sjogren’s syndrome
    Nishanthi Thalayasingam, Kelly Baldwin, Claire Judd, Wan‐Fai Ng · 2021 · Rheumatology
  14. Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren’s Syndrome
    Ning Li, Lei Li, Mengyao Wu, Yusi Li, Jie Yang, Yi‐Cheng Wu, Haimin Xu, Danyang Luo, Yiming Gao, Xiaochun Fei et al. · 2021 · Frontiers in Immunology
  15. The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials
    Renaud Felten, Florence Scher, Jean Sibilia, Jacques‐Eric Gottenberg, Laurent Arnaud · 2019 · Autoimmunity Reviews
  16. The Role of Regulatory T Cells in the Onset and Progression of Primary Sjögren’s Syndrome
    Varvara G. Blinova, Vladimir Ivanovich Vasilyev, Ekaterina B. Rodionova, Dmitry D. Zhdanov · 2023 · Cells
  17. B cells in Sjögren’s syndrome: from pathophysiology to therapeutic target
    Julie Mielle, Alice Tison, Divi Cornec, Laëtitia Le Pottier, C. Daïen, Jacques‐Olivier Pers · 2018 · Rheumatology
  18. Management of primary Sjögren’s syndrome: recent developments and new classification criteria
    Nicoletta Del Papa, Claudio Vitali · 2018 · Therapeutic Advances in Musculoskeletal Disease
  19. Rituximab Therapy for Primary Sjögren’s Syndrome
    Yi Han Chen, Xinyu Wang, Xin Jin, Zi Feng Yang, Jianguang Xu · 2021 · Frontiers in Pharmacology
  20. Tolerability and safety of long-term rituximab treatment in systemic inflammatory and autoimmune diseases
    Jens Vikse, Kristín Jónsdóttir, Jan Terje Kvaløy, Klaus Wildhagen, Roald Omdal · 2019 · Rheumatology International
  21. Recomendações para o tratamento da síndrome de Sjögren
    Valéria Valim, Virgínia Fernandes Moça Trevisani, Sandra Gofinet Pasoto, Érica Vieira Serrano, Sandra Lúcia Euzébio Ribeiro, Tania Fidelix, Verônica Silva Vilela, Leandro Lara do Prado, Leandro Augusto Tanure, Tatiana Nayara Libório‐Kimura et al. · 2015 · Revista Brasileira de Reumatologia
  22. Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections
    Manuela Di Franco, Bruno Lucchino, Martina Spaziante, Cristina Iannuccelli, Guido Valesini, Giancarlo Iaiani · 2017 · International Journal of Molecular Sciences
  23. Immunoresponsive Autonomic Neuropathy in Sjögren Syndrome—Case Series and Literature Review
    Brent P. Goodman · 2017 · American Journal of Therapeutics
  24. Pulmonary and Bronchiolar Involvement in Sjogren's Syndrome
    Augustine Chung, M.L. Wilgus, Gregory A. Fishbein, Joseph P. Lynch · 2019 · Seminars in Respiratory and Critical Care Medicine
  25. Cytotoxic CD8+ T cells may be drivers of tissue destruction in Sjögren’s syndrome
    Naoki Kaneko, Hu Chen, Cory A. Perugino, Takashi Maehara, Ryusuke Munemura, Shiho Yokomizo, Junsei Sameshima, Thomas J. Diefenbach, Katherine R. Premo, Akira Chinju et al. · 2022 · Scientific Reports
  26. Fatigue in psoriasis: a phenomenon to be explored
    Inger Marie Skoie, Th. Ternowitz, Grete Jonsson, Katrine Brække Norheim, Roald Omdal · 2014 · British Journal of Dermatology
  27. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist’s point of view
    So‐My Koo, Soo‐Taek Uh · 2017 · The Korean Journal of Internal Medicine
  28. Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sjögren’s syndrome
    Eefje Hanna Martine van der Heijden, Sarita A. Y. Hartgring, Aike Albert Kruize, Timothy R. D. J. Radstake, Joël A. G. van Roon · 2019 · Expert Review of Clinical Immunology
  29. Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation
    Chiara Rizzo, Giulia Grasso, Giulia Maria Destro Castaniti, Francesco Ciccia, Giuliana Guggino · 2020 · Vaccines
  30. Current status of imaging of Sjogren's syndrome
    Sandrine Jousse‐Joulin, Guillaume Coiffier · 2020 · Best Practice & Research Clinical Rheumatology
  31. A randomized, double-blind, placebo-controlled, parallel group study on the effects of a cathepsin S inhibitor in primary Sjögren’s syndrome
    Darren J. Bentley, Benjamin A. Fisher, Francesca Barone, Fabrice A. Kolb, Gemma Attley · 2023 · Lara D. Veeken
  32. Interferon activation in primary Sjögren’s syndrome: recent insights and future perspective as novel treatment target
    Iris L. A. Bodewes, Marjan A. Versnel · 2018 · Expert Review of Clinical Immunology
  33. Managing fatigue in patients with primary Sjögren’s syndrome: challenges and solutions
    Samira Tatiyama Miyamoto, Dennis William Lendrem, Wan‐Fai Ng, Katie L. Hackett, Valéria Valim · 2019 · Open Access Rheumatology Research and Reviews
  34. PROSPECTS FOR ANTI-B-CELL THERAPY IN IMMUNO-INFLAMMATORY RHEUMATIC DISEASES
    Evgeny Lvovich Nasonov, Tatiana Valentinovna Beketova, L. P. Ananyeva, Vladimir Ivanovich Vasilyev, Sergey K. Solovyev, Anastasia Sergeevna Avdeeva · 2019 · Rheumatology Science and Practice
  35. Management of Sjögren's Syndrome: Present Issues and Future Perspectives
    Claudio Vitali, Antonina Minniti, Francesca Serena Pignataro, Wanda Maglione, Nicoletta Del Papa · 2021 · Frontiers in Medicine
  36. Time-course of ultrasound abnormalities of major salivary glands in suspected Sjögren's syndrome
    Pierre Gazeau, Divi Cornec, Sandrine Jousse‐Joulin, Dewi Guellec, Alain Saraux, Valérie Devauchelle‐Pensec · 2017 · Joint Bone Spine
  37. How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patients
    Hoda Gheitasi, Belchin Kostov, Roser Solans, Guadalupe Fraile, Carlos Suárez-Cuervo, A. Casanovas, F.J. Rascón, Rami Qanneta, R. Pérez-Álvarez, Mar Ripoll et al. · 2015 · International Immunopharmacology
  38. Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study
    Thomas Dörner, Simon Bowman, Robert I. Fox, Xavier Mariette A, Athena Papas, Thomas Grader‐Beck, Benjamin A. Fisher, Filipe Barcelos, Salvatore De Vita, Hendrik Schulze‐Koops et al. · 2024 · Arthritis & Rheumatology
  39. Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren’s syndrome
    Gwenny M. P. J. Verstappen, Rada V. Moerman, Jolien F. van Nimwegen, Martha S. van Ginkel, Johan Bijzet, Esther Mossel, Arjan Vissink, Bouke P. C. Hazenberg, Suzanne Arends, Frans G. M. Kroese et al. · 2018 · Lara D. Veeken
  40. Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review
    Mattia Bellan, Filippo Patrucco, Francesco Barone‐Adesi, Francesco Gavelli, Luigi Mario Castello, Alessandra Nerviani, Laura Andréoli, Lorenzo Cavagna, Mario Pirisi, Pier Paolo Sainaghi · 2019 · Autoimmunity Reviews
  41. Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
    Piero Ruscitti, Yannick Allanore, Chiara Baldini, Giuseppe Barilaro, Elena Bartoloni Bocci, Pietro Bearzi, Elisa Bellis, Onorina Berardicurti, Alice Biaggi, Michele Bombardieri et al. · 2024 · Autoimmunity Reviews
  42. Is There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases?
    Devis Benfaremo, Armando Gabrielli · 2019 · Cells
  43. Use of Biologics in Sjögren's Syndrome
    Gaëtane Nocturne, Divi Cornec, Raphaèle Séror, Xavier Mariette · 2016 · Rheumatic Disease Clinics of North America
  44. Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments
    Gita Manzari Tavakoli, Niloufar Yazdanpanah, Nima Rezaei · 2024 · Revista Brasileira de Reumatologia
  45. Primary Sjögren’s Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)
    Simon Bowman, Raphaèle Séror, Raphaël Porcher, Suzanne Arends, Liseth de Wolff, Gwenny M. P. J. Verstappen, Valérie Devauchelle‐Pensec, Sandrine Jousse‐Joulin, Chiara Baldini, Michele Bombardieri et al. · 2025 · Annals of the Rheumatic Diseases
  46. Primary Sjögren's syndrome and occupational risk factors: A case–control study
    Benjamin Chaigne, Gérard Lasfargues, Isabelle Marié, Brigitte Huttenberger, Christian Lavigne, Sylvain Marchand-Adam, F. Maillot, Élisabeth Diot · 2015 · Journal of Autoimmunity
  47. Current and future treatment in primary Sjögren's syndrome – A still challenging development
    Jacob Ritter, Yidan Chen, Ana‐Luisa Stefanski, Thomas Dörner · 2022 · Joint Bone Spine
  48. Autoantibody pain
    Andreas Göebel · 2016 · Autoimmunity Reviews
  49. Estimated prevalence, incidence and healthcare costs of Sjögren’s syndrome in France: a national claims-based study
    Raphaèle Séror, Laurent Chiche, Maxime Beydon, Guillaume Desjeux, Joe Zhuo, Virginie Vannier-Moreau, Valérie Devauchelle‐Pensec · 2024 · RMD Open
  50. Multiple Roles for B-Lymphocytes in Sjogren’s Syndrome
    Julian L. Ambrus, Lakshmanan Suresh, Ammon B. Peck · 2016 · Journal of Clinical Medicine
  51. Patient burden of Sjögren’s: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity
    Katherine M. Hammitt, April N. Naegeli, Rémon W M van den Broek, Julie A. Birt · 2017 · RMD Open
  52. Meta‐Analysis of Treatment for Primary Sjögren's Syndrome
    Lucy L. Chu, Kangping Cui, Janet Elizabeth Pope · 2019 · Arthritis Care & Research
  53. World Workshop on Oral Medicine VII : Immunobiologics for salivary gland disease in Sjögren's syndrome: A systematic review
    Luiz Alcino Gueiros, Katherine France, Rachael Posey, Jacqueline Wiesehan Mays, Barbara Carey, Thomas Peter Sollecito, Jane F. Setterfield, Sook Bin Woo, Donna Aline Culton, Aimee S. Payne et al. · 2019 · Oral Diseases
  54. Clinical practice guidance for Sjögren’s syndrome in pediatric patients (2018) – summarized and updated
    Minako Tomiita, Ichiro Kobayashi, Yasuhiko Itoh, Yuzaburo Inoue, Naomi Iwata, Hiroaki Umebayashi, Nami Okamoto, Yukiko Nonaka, Ryoki Hara, Masaaki Mori · 2020 · Modern Rheumatology
  55. Rituximab in primary Sjögren's syndrome: a ten-year journey
    Francesco Carubbi, Alessia Alunno, Paola Cipriani, Elena Bartoloni, Francesco Ciccia, G Triolo, Roberto Gerli, Roberto Giacomelli · 2014 · Lupus
  56. B-cell and T-cell quantification in minor salivary glands in primary Sjögren’s syndrome: development and validation of a pixel-based digital procedure
    Sebastian Costa, Sacha Schutz, Divi Cornec, Arnaud Uguen, Isabelle Quintin‐Roué, Agnès Lesourd, Jean‐Marie Berthelot, Eric HACHULLA, Pierre‐Yves Hatron, Vincent Goëb et al. · 2016 · Arthritis Research & Therapy
  57. Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome?
    Valérie Devauchelle‐Pensec, Jacques‐Eric Gottenberg, Sandrine Jousse‐Joulin, Jean‐Marie Berthelot, Aleth Perdriger, Eric HACHULLA, Pierre‐Yves Hatron, Xavier Puéchal, Véronique Le Guern, Jean Sibilia et al. · 2015 · PLoS ONE
  58. Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)
    Elena Pontarini, Elisabetta Sciacca, Farzana Chowdhury, Sofia Grigoriadou, Felice Rivellese, William Murray‐Brown, Davide Lucchesi, Liliane Fossati‐Jimack, Alessandra Nerviani, Edyta Jaworska et al. · 2023 · Arthritis & Rheumatology
  59. Optimizing conventional DMARD therapy for Sjögren's syndrome
    Eefje Hanna Martine van der Heijden, Aike Albert Kruize, Timothy R. D. J. Radstake, Joël A. G. van Roon · 2018 · Autoimmunity Reviews
  60. Advances in the treatment of ocular dryness associated with Sjögren׳s syndrome
    Coziana Ciurtin, Anca Ostas, Viorica Mădălina Cojocaru, Stephen B. Walsh, David Alan Isenberg · 2015 · Seminars in Arthritis and Rheumatism
  61. Do high numbers of salivary gland-infiltrating B cells predict better or worse outcomes after rituximab in patients with primary Sjögren's syndrome?
    Divi Cornec, Sebastian Costa, Valérie Devauchelle‐Pensec, Laurent Chiche, Alain Saraux, Jacques‐Olivier Pers · 2016 · Annals of the Rheumatic Diseases
  62. Mixed‐Methods Study Identifying Key Intervention Targets to Improve Participation in Daily Living Activities in Primary Sjögren's Syndrome Patients
    Katie L. Hackett, Katherine HO Deane, Julia L. Newton, Vincent Deary, Simon Bowman, Tim Rapley, Wan‐Fai Ng, United Kingdom Primary Sjögren's Syndrome Registry · 2018 · Arthritis Care & Research
  63. Defining the Role of Monocytes in Sjögren’s Syndrome
    José Miguel Sequí-Sabater, Lorenzo Beretta · 2022 · International Journal of Molecular Sciences
  64. Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome
    Mucong Li, Mengtao Li, Qiao Lin, Chanyuan Wu, Dong He Xu, Yan Mei Zhao, Xiaofeng Zeng · 2023 · Chinese Medical Journal
  65. SHED ‐exos promote saliva secretion by suppressing p‐ ERK1 /2‐mediated apoptosis in glandular cells
    Wei‐Xia Chu, Chong Ding, Zhihao Du, Pan Wei, Yi‐Xiang Wang, Xue‐Jun Ge, Guang‐Yan Yu · 2023 · Oral Diseases
  66. How to treat Sjögren’s syndrome
    Elizabeth Price, Alan N. Baer · 2018 · Lara D. Veeken
  67. Engineering Cell Therapies for Autoimmune Diseases: From Preclinical to Clinical Proof of Concept
    Sangwook Oh, Aimee S. Payne · 2022 · Immune Network
  68. Expression of Toll-Like Receptor -7 and -9 in B Cell Subsets from Patients with Primary Sjögren’s Syndrome
    Marie Karlsen, Torbjørn Hansen, Hilde Haugedal Nordal, Johan Gorgas Brun, Roland Jonsson, Silke Appel · 2015 · PLoS ONE
  69. Orofacial manifestations in patients with inflammatory rheumatic diseases
    John Hamburger · 2016 · Best Practice & Research Clinical Rheumatology
  70. The reporting of harms in publications on randomized controlled trials funded by the “Programme Hospitalier de Recherche Clinique,” a French academic funding scheme
    Favier, Romain, Crépin, Sabrina · 2018 · Clinical Trials
  71. One year in review 2015: Sjögren's syndrome.
    Nicoletta Luciano, Valentina Valentini, Andrea Calabrò, Elena Elefante, Antonio Vitale, Chiara Baldini, Elena Bartoloni · 2015 · PubMed
  72. Targeted Therapy for Primary Sjögren’s Syndrome: Where are We Now?
    Bin Wang, Shiju Chen, Yan Li, Jingxiu Xuan, Yuan Liu, Guixiu Shi · 2021 · BioDrugs
  73. Sjögren Syndrome
    Robert I. Fox, Carla M. Fox · 2016 · Rheumatic Disease Clinics of North America
  74. Increased proportion of a CD38highIgD+ B cell subset in peripheral blood is associated with clinical and immunological features in patients with primary Sjögren's syndrome
    E. Ishioka, Keiko Yoshimoto, Katsuya Suzuki, Ayumi Nishikawa, Hidekata Yasuoka, Kunihiro Yamaoka, Tsutomu Takeuchi · 2017 · Clinical Immunology
  75. Present and future of biologic drugs in primary Sjögren’s syndrome
    Domenico Sambataro, Gianluca Sambataro, Ylenia Dal Bosco, Riccardo Polosa · 2016 · Expert Opinion on Biological Therapy
  76. Toward better outcomes in Sjögren's syndrome: The promise of a stratified medicine approach
    Ghaith Noaiseh, Alan N. Baer · 2020 · Best Practice & Research Clinical Rheumatology
  77. The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren’s syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial
    Xia Liu, Xiaomei Li, Xiang-Pei Li, Zhijun Li, Dongbao Zhao, Shengyun Liu, Miaojia Zhang, Zhang Fengxiao, Ping Zhu, Jinwei Chen et al. · 2018 · Clinical Rheumatology
  78. Biological Therapy in Primary Sjögren's Syndrome: Effect on Salivary Gland Function and Inflammation
    Farzana Chowdhury, Anwar R. Tappuni, Michele Bombardieri · 2021 · Frontiers in Medicine
  79. The Future of Targeted Treatment of Primary Sjögren’s Syndrome: A Focus on Extra-Glandular Pathology
    Weizhen Zeng, Xinyao Zhou, Ruihua Liu, Chrystie Wan Ning Quek, Vincent Ho Chit Yu, Ryan Yong Kiat Tay, 于素兰, Bo Yang, Xiang Lin, Yun Feng · 2022 · International Journal of Molecular Sciences
  80. Eligibility for clinical trials in primary Sjögren’s syndrome: lessons from the UK Primary Sjögren’s Syndrome Registry
    Clare Oni, Sheryl Mitchell, Katherine James, Wan‐Fai Ng, Bridget Griffiths, Victoria Hindmarsh, Elizabeth Price, Colin Thomas Pease, Paul Emery, Peter Lanyon et al. · 2015 · Lara D. Veeken
  81. Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases
    Pilar Uribe-Reina, Juliana Muñoz-Ortiz, Carlos Cifuentes‐González, Juliana Reyes-Guanes, Juan Pablo Terreros-Dorado, William Zambrano-Romero, Carolina Lopez-Rojas, Fabien Mantilla-Sylvain, Rubén Dario Mantilla-Hernández, Alejandra de‐la‐Torre · 2021 · Clinical ophthalmology
  82. Sjögren’s and non-Sjögren’s sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature
    Valentina Pucino, Jason D. Turner, Saba Nayar, Florian Kollert, Saaeha Rauz, Andrea Richards, Jon Higham, Ana Poveda‐Gallego, Simon Bowman, Francesca Barone et al. · 2022 · RMD Open
  83. Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal?
    Kristina Schreiber, Gaëtane Nocturne, Divi Cornec, C. Daïen · 2017 · Clinical Reviews in Allergy & Immunology
  84. Recent advances in the search for a targeted immunomodulatory therapy for primary Sjögren’s syndrome
    David L. Leverenz, E. William St. Clair · 2019 · F1000Research
  85. Xerostomia: current streams of investigation
    Ryan L. Quock · 2016 · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
  86. Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects
    Pilar Brito‐Zerón, Soledad Retamozo, Hoda Gheitasi, Manuel Ramos‐Casals · 2016 · Drugs
  87. RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis
    M Tahara, Hiroto Tsuboi, Seiji Segawa, Hiromitsu Asashima, Mana Iizuka-Koga, T Hirota, Hidenori Takahashi, Yuya Kondo, Masanori Matsui, Isao Matsumoto et al. · 2016 · Clinical & Experimental Immunology
  88. Safety and efficacy of rituximab in connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis
    Nanshu Xing, Guanzhi Fan, Fei Yan, Yiping Liu, Rong Zhang · 2021 · International Immunopharmacology
  89. Primary Sjögren's syndrome at a glance today
    Pierre Youinou, Jacques‐Olivier Pers · 2015 · Joint Bone Spine
  90. Current developments and opportunities of pluripotent stem cells-based therapies for salivary gland hypofunction
    Wenpeng Song, Huan Liu, Yingying Su, Qian Zhao, Xiaoyan Wang, Pengfei Cheng, Hao Wang · 2024 · Frontiers in Cell and Developmental Biology
  91. Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets
    Jacob Ritter, Franziska Szelinski, Arman Aue, Ana‐Luisa Stefanski, Héctor Rincón-Arévalo, Yidan Chen, Eduard Nitschke, Van Duc Dang, Annika Wiedemann, Eva Vanessa Schrezenmeier et al. · 2024 · Journal of Autoimmunity
  92. Serological lymphocytic activity and patient-reported outcomes in Sjögren’s syndrome
    Maike Jülich, Anna‐Maria Kanne, Bettina Sehnert, Stephan Budweiser, Reinhard Edmund Voll, Florian Kollert · 2018 · Clinical Rheumatology
  93. Safety of treatments for primary Sjögren’s syndrome
    Jolien F. van Nimwegen, Rada V. Moerman, Nicole Sillevis Smitt-Kamminga, Elisabeth Brouwer, Hendrika Bootsma, Arjan Vissink · 2016 · Expert Opinion on Drug Safety
  94. Emerging drugs for primary Sjögren’s syndrome
    Saviana Gandolfo, Salvatore De Vita · 2019 · Expert Opinion on Emerging Drugs
  95. Editorial: Rituximab in the Treatment of Sjögren's Syndrome: Is It the Right or Wrong Drug?
    Hendrika Bootsma, Frans G. M. Kroese, Arjan Vissink · 2017 · Arthritis & Rheumatology
  96. Primary Sjögren’s Syndrome: A Retrospective Cohort Study of Burden of Illness in Sweden
    Anna Westerlund, Anne Mette Tranberg Kejs, H. Beydogan, Kerry Gairy · 2021 · Rheumatology and Therapy
  97. Abatacept ameliorates both glandular and extraglandular involvements in patients with Sjögren’s syndrome associated with rheumatoid arthritis: Findings from an open-label, multicentre, 1-year, prospective study: The ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren’s Syndrome Endocrinopathy) and ROSE II trials
    Hiroto Tsuboi, Hirofumi Toko, Fumika Honda, Saori Abe, Hiroyuki Takahashi, Mizuki Yagishita, Shinya Hagiwara, Ayako Ohyama, Yuya Kondo, Kazuhisa Nakano et al. · 2022 · Modern Rheumatology
  98. French national diagnostic and care protocol for Sjögren's disease
    Valérie Devauchelle‐Pensec, Xavier Mariette, Anas‐Alexis Benyoussef, Sylvie Boisramé, Béatrice Cochener, Divi Cornec, Gaëtane Nocturne, Jacques‐Eric Gottenberg, Eric HACHULLA, P. Labalette et al. · 2023 · La Revue de Médecine Interne
  99. The continuing evolution of targeted therapy for inflammatory skin disease
    Christoph Schlapbach, Alexander Andreas Navarini · 2015 · Seminars in Immunopathology
  100. Actualités dans le syndrome de Sjögren primitif : aspects cliniques et thérapeutiques
    Gaëtane Nocturne · 2019 · La Revue de Médecine Interne